nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—HSP90AA1—pons—malignant glioma	0.0539	0.19	CbGeAlD
Nedocromil—HSP90AA1—pineal body—malignant glioma	0.0385	0.136	CbGeAlD
Nedocromil—HSP90AA1—endothelium—malignant glioma	0.0238	0.0841	CbGeAlD
Nedocromil—HSP90AA1—blood vessel—malignant glioma	0.022	0.0775	CbGeAlD
Nedocromil—FPR1—central nervous system—malignant glioma	0.0167	0.0589	CbGeAlD
Nedocromil—PTGDR—central nervous system—malignant glioma	0.0158	0.0556	CbGeAlD
Nedocromil—HSP90AA1—embryo—malignant glioma	0.0131	0.0462	CbGeAlD
Nedocromil—PTGDR—brain—malignant glioma	0.0125	0.0442	CbGeAlD
Nedocromil—HSP90AA1—brainstem—malignant glioma	0.012	0.0424	CbGeAlD
Nedocromil—HSP90AA1—retina—malignant glioma	0.0116	0.0409	CbGeAlD
Nedocromil—HSP90AA1—telencephalon—malignant glioma	0.0107	0.0376	CbGeAlD
Nedocromil—HSP90AA1—medulla oblongata—malignant glioma	0.00837	0.0295	CbGeAlD
Nedocromil—HSP90AA1—midbrain—malignant glioma	0.00765	0.027	CbGeAlD
Nedocromil—HSP90AA1—spinal cord—malignant glioma	0.00746	0.0263	CbGeAlD
Nedocromil—CYSLTR1—central nervous system—malignant glioma	0.00698	0.0246	CbGeAlD
Nedocromil—HSP90AA1—central nervous system—malignant glioma	0.00605	0.0214	CbGeAlD
Nedocromil—HSP90AA1—cerebellum—malignant glioma	0.00592	0.0209	CbGeAlD
Nedocromil—Disorder sight—Temozolomide—malignant glioma	0.00574	0.0887	CcSEcCtD
Nedocromil—CYSLTR1—brain—malignant glioma	0.00554	0.0196	CbGeAlD
Nedocromil—HSP90AA1—brain—malignant glioma	0.00481	0.017	CbGeAlD
Nedocromil—Otitis media—Temozolomide—malignant glioma	0.00351	0.0542	CcSEcCtD
Nedocromil—Viral infection—Temozolomide—malignant glioma	0.00303	0.0468	CcSEcCtD
Nedocromil—Ear pain—Temozolomide—malignant glioma	0.00233	0.0359	CcSEcCtD
Nedocromil—Gastroenteritis—Temozolomide—malignant glioma	0.00224	0.0346	CcSEcCtD
Nedocromil—Nasal congestion—Temozolomide—malignant glioma	0.00218	0.0337	CcSEcCtD
Nedocromil—Bronchitis—Temozolomide—malignant glioma	0.00165	0.0255	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00159	0.0246	CcSEcCtD
Nedocromil—Pneumonia—Carmustine—malignant glioma	0.00159	0.0246	CcSEcCtD
Nedocromil—Pneumonia—Temozolomide—malignant glioma	0.00154	0.0238	CcSEcCtD
Nedocromil—Sinusitis—Temozolomide—malignant glioma	0.00143	0.0222	CcSEcCtD
Nedocromil—Visual impairment—Carmustine—malignant glioma	0.00137	0.0212	CcSEcCtD
Nedocromil—Pharyngitis—Temozolomide—malignant glioma	0.00136	0.0211	CcSEcCtD
Nedocromil—Visual impairment—Temozolomide—malignant glioma	0.00132	0.0204	CcSEcCtD
Nedocromil—Dysgeusia—Temozolomide—malignant glioma	0.00117	0.0181	CcSEcCtD
Nedocromil—Tremor—Carmustine—malignant glioma	0.00116	0.0179	CcSEcCtD
Nedocromil—Tremor—Temozolomide—malignant glioma	0.00112	0.0173	CcSEcCtD
Nedocromil—Leukopenia—Carmustine—malignant glioma	0.00111	0.0171	CcSEcCtD
Nedocromil—Leukopenia—Temozolomide—malignant glioma	0.00107	0.0165	CcSEcCtD
Nedocromil—Chest pain—Carmustine—malignant glioma	0.00105	0.0163	CcSEcCtD
Nedocromil—Cough—Temozolomide—malignant glioma	0.00104	0.0161	CcSEcCtD
Nedocromil—Dry mouth—Temozolomide—malignant glioma	0.000995	0.0154	CcSEcCtD
Nedocromil—Anaphylactic shock—Temozolomide—malignant glioma	0.000975	0.0151	CcSEcCtD
Nedocromil—Dyspnoea—Carmustine—malignant glioma	0.0009	0.0139	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Carmustine—malignant glioma	0.000871	0.0135	CcSEcCtD
Nedocromil—Dyspnoea—Temozolomide—malignant glioma	0.00087	0.0134	CcSEcCtD
Nedocromil—Pain—Carmustine—malignant glioma	0.000863	0.0133	CcSEcCtD
Nedocromil—Dyspepsia—Temozolomide—malignant glioma	0.000859	0.0133	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000842	0.013	CcSEcCtD
Nedocromil—Fatigue—Temozolomide—malignant glioma	0.000841	0.013	CcSEcCtD
Nedocromil—Pain—Temozolomide—malignant glioma	0.000834	0.0129	CcSEcCtD
Nedocromil—Gastrointestinal pain—Carmustine—malignant glioma	0.000825	0.0128	CcSEcCtD
Nedocromil—Abdominal pain—Carmustine—malignant glioma	0.000798	0.0123	CcSEcCtD
Nedocromil—Body temperature increased—Carmustine—malignant glioma	0.000798	0.0123	CcSEcCtD
Nedocromil—Gastrointestinal pain—Temozolomide—malignant glioma	0.000798	0.0123	CcSEcCtD
Nedocromil—Urticaria—Temozolomide—malignant glioma	0.000775	0.012	CcSEcCtD
Nedocromil—Body temperature increased—Temozolomide—malignant glioma	0.000771	0.0119	CcSEcCtD
Nedocromil—Abdominal pain—Temozolomide—malignant glioma	0.000771	0.0119	CcSEcCtD
Nedocromil—Hypersensitivity—Carmustine—malignant glioma	0.000744	0.0115	CcSEcCtD
Nedocromil—Asthenia—Carmustine—malignant glioma	0.000724	0.0112	CcSEcCtD
Nedocromil—Hypersensitivity—Temozolomide—malignant glioma	0.000719	0.0111	CcSEcCtD
Nedocromil—Asthenia—Temozolomide—malignant glioma	0.0007	0.0108	CcSEcCtD
Nedocromil—Diarrhoea—Carmustine—malignant glioma	0.000691	0.0107	CcSEcCtD
Nedocromil—Dizziness—Carmustine—malignant glioma	0.000667	0.0103	CcSEcCtD
Nedocromil—Diarrhoea—Temozolomide—malignant glioma	0.000667	0.0103	CcSEcCtD
Nedocromil—Dizziness—Temozolomide—malignant glioma	0.000645	0.00996	CcSEcCtD
Nedocromil—Vomiting—Carmustine—malignant glioma	0.000642	0.00991	CcSEcCtD
Nedocromil—Rash—Carmustine—malignant glioma	0.000636	0.00983	CcSEcCtD
Nedocromil—Dermatitis—Carmustine—malignant glioma	0.000636	0.00982	CcSEcCtD
Nedocromil—Headache—Carmustine—malignant glioma	0.000632	0.00977	CcSEcCtD
Nedocromil—Vomiting—Temozolomide—malignant glioma	0.00062	0.00958	CcSEcCtD
Nedocromil—Rash—Temozolomide—malignant glioma	0.000615	0.0095	CcSEcCtD
Nedocromil—Dermatitis—Temozolomide—malignant glioma	0.000614	0.00949	CcSEcCtD
Nedocromil—Headache—Temozolomide—malignant glioma	0.000611	0.00944	CcSEcCtD
Nedocromil—Nausea—Carmustine—malignant glioma	0.0006	0.00926	CcSEcCtD
Nedocromil—Nausea—Temozolomide—malignant glioma	0.000579	0.00895	CcSEcCtD
Nedocromil—CYSLTR1—Signaling Pathways—CDKN2B—malignant glioma	0.000145	0.000223	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PTPN11—malignant glioma	0.000145	0.000222	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PIK3CB—malignant glioma	0.000144	0.000221	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—H3F3A—malignant glioma	0.000144	0.000221	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CXCL8—malignant glioma	0.000143	0.00022	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCR3—malignant glioma	0.000143	0.000219	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HES1—malignant glioma	0.000142	0.000218	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NCOR1—malignant glioma	0.000141	0.000216	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PTK2—malignant glioma	0.000141	0.000216	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CXCL8—malignant glioma	0.00014	0.000215	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—YWHAE—malignant glioma	0.000139	0.000213	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NTRK2—malignant glioma	0.000139	0.000213	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—BRAF—malignant glioma	0.000139	0.000213	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HES1—malignant glioma	0.000138	0.000212	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—AKT1—malignant glioma	0.000138	0.000212	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CXCL8—malignant glioma	0.000138	0.000212	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FLT1—malignant glioma	0.000138	0.000212	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NCOR1—malignant glioma	0.000138	0.000211	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—DUSP6—malignant glioma	0.000137	0.000211	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CASP3—malignant glioma	0.000137	0.00021	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL2—malignant glioma	0.000137	0.00021	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—RAF1—malignant glioma	0.000136	0.000208	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—JAG1—malignant glioma	0.000136	0.000208	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NOTCH3—malignant glioma	0.000135	0.000207	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PDGFRA—malignant glioma	0.000135	0.000207	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AKT2—malignant glioma	0.000135	0.000207	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HLA-A—malignant glioma	0.000135	0.000207	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—EGFR—malignant glioma	0.000134	0.000206	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—IL2—malignant glioma	0.000134	0.000206	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—AKT1—malignant glioma	0.000134	0.000205	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FBXW7—malignant glioma	0.000133	0.000204	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—PIK3CB—malignant glioma	0.000133	0.000203	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CASP3—malignant glioma	0.000132	0.000203	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL2—malignant glioma	0.000132	0.000203	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—VEGFA—malignant glioma	0.000132	0.000202	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PDGFRA—malignant glioma	0.000132	0.000202	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PDGFB—malignant glioma	0.000131	0.000202	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—FGFR1—malignant glioma	0.000131	0.000201	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—STAT3—malignant glioma	0.000131	0.0002	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—BDKRB2—malignant glioma	0.00013	0.0002	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PIK3CD—malignant glioma	0.00013	0.000199	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MMP9—malignant glioma	0.00013	0.000199	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—PTEN—malignant glioma	0.000129	0.000198	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PTEN—malignant glioma	0.000129	0.000198	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GSTP1—malignant glioma	0.000129	0.000197	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—PIK3CA—malignant glioma	0.000128	0.000197	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SPP1—malignant glioma	0.000128	0.000196	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CXCL8—malignant glioma	0.000127	0.000195	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—KRAS—malignant glioma	0.000127	0.000195	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—AKT1—malignant glioma	0.000126	0.000193	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—MYC—malignant glioma	0.000126	0.000193	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MMP9—malignant glioma	0.000125	0.000192	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CAT—malignant glioma	0.000125	0.000192	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PTEN—malignant glioma	0.000124	0.000191	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TERT—malignant glioma	0.000124	0.000191	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HLA-A—malignant glioma	0.000124	0.000191	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—FGF2—malignant glioma	0.000124	0.00019	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL2—malignant glioma	0.000122	0.000187	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—AKT1—malignant glioma	0.000121	0.000186	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PDGFB—malignant glioma	0.000121	0.000186	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TERT—malignant glioma	0.000121	0.000186	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NOTCH2—malignant glioma	0.000121	0.000186	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—FGFR1—malignant glioma	0.000121	0.000185	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HIF1A—malignant glioma	0.000119	0.000182	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—EGFR—malignant glioma	0.000119	0.000182	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KNG1—malignant glioma	0.000119	0.000182	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PDGFB—malignant glioma	0.000118	0.000182	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—NCOR1—malignant glioma	0.000118	0.000181	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FGFR1—malignant glioma	0.000118	0.000181	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—BAD—malignant glioma	0.000117	0.00018	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—PIK3CA—malignant glioma	0.000117	0.000179	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—VEGFA—malignant glioma	0.000116	0.000178	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MDM2—malignant glioma	0.000116	0.000178	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HIF1A—malignant glioma	0.000116	0.000178	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—RAF1—malignant glioma	0.000116	0.000177	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—STAT3—malignant glioma	0.000115	0.000177	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CAV1—malignant glioma	0.000115	0.000176	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ERBB2—malignant glioma	0.000114	0.000176	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD80—malignant glioma	0.000114	0.000174	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TNF—malignant glioma	0.000113	0.000173	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NTRK1—malignant glioma	0.000113	0.000173	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PIK3CB—malignant glioma	0.000113	0.000173	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—VEGFA—malignant glioma	0.000112	0.000172	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—MYC—malignant glioma	0.000112	0.000172	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CAV1—malignant glioma	0.000112	0.000172	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—EGF—malignant glioma	0.000112	0.000172	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—KRAS—malignant glioma	0.000112	0.000172	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PTPN11—malignant glioma	0.000111	0.000171	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—STAT3—malignant glioma	0.000111	0.000171	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KDR—malignant glioma	0.000111	0.00017	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CXCL8—malignant glioma	0.000109	0.000167	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—BAD—malignant glioma	0.000108	0.000166	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NOTCH1—malignant glioma	0.000107	0.000164	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MYC—malignant glioma	0.000107	0.000164	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FN1—malignant glioma	0.000107	0.000164	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—F2—malignant glioma	0.000107	0.000164	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—BAD—malignant glioma	0.000106	0.000162	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MMP3—malignant glioma	0.000105	0.000161	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CD80—malignant glioma	0.000105	0.000161	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—AKT1—malignant glioma	0.000105	0.000161	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—EGFR—malignant glioma	0.000105	0.000161	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—APC—malignant glioma	0.000105	0.000161	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—EGFR—malignant glioma	0.000105	0.000161	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NOTCH1—malignant glioma	0.000105	0.00016	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CDKN2B—malignant glioma	0.000104	0.00016	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CASP3—malignant glioma	0.000104	0.000159	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—AKT2—malignant glioma	0.000104	0.000159	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL2—malignant glioma	0.000104	0.000159	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—EGF—malignant glioma	0.000104	0.000159	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MYC—malignant glioma	0.000103	0.000159	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PTPN11—malignant glioma	0.000103	0.000158	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CD80—malignant glioma	0.000102	0.000157	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—APC—malignant glioma	0.000102	0.000157	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PIK3CG—malignant glioma	0.000102	0.000157	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PTK2—malignant glioma	0.000101	0.000155	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—EGFR—malignant glioma	0.000101	0.000155	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EGF—malignant glioma	0.000101	0.000155	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PTPN11—malignant glioma	0.0001	0.000154	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PIK3CD—malignant glioma	9.97e-05	0.000153	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HES1—malignant glioma	9.94e-05	0.000152	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—KRAS—malignant glioma	9.9e-05	0.000152	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—KRAS—malignant glioma	9.89e-05	0.000152	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NCOR1—malignant glioma	9.88e-05	0.000152	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—BRAF—malignant glioma	9.85e-05	0.000151	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MMP9—malignant glioma	9.82e-05	0.000151	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PTEN—malignant glioma	9.76e-05	0.00015	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CAV1—malignant glioma	9.63e-05	0.000148	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—BRAF—malignant glioma	9.61e-05	0.000147	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—AKT2—malignant glioma	9.58e-05	0.000147	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—KRAS—malignant glioma	9.55e-05	0.000147	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—FGF2—malignant glioma	9.55e-05	0.000146	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—AKT1—malignant glioma	9.52e-05	0.000146	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PDGFRA—malignant glioma	9.46e-05	0.000145	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AKT2—malignant glioma	9.35e-05	0.000143	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—EGFR—malignant glioma	9.31e-05	0.000143	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TP53—malignant glioma	9.23e-05	0.000142	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PIK3CD—malignant glioma	9.21e-05	0.000141	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SPP1—malignant glioma	9.18e-05	0.000141	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—PIK3CA—malignant glioma	9.1e-05	0.00014	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PIK3CA—malignant glioma	9.09e-05	0.000139	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—BCL2—malignant glioma	9.07e-05	0.000139	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IFNG—malignant glioma	8.99e-05	0.000138	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PIK3CD—malignant glioma	8.98e-05	0.000138	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MDM2—malignant glioma	8.94e-05	0.000137	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—RAF1—malignant glioma	8.9e-05	0.000137	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—PIK3CA—malignant glioma	8.9e-05	0.000136	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—VEGFA—malignant glioma	8.82e-05	0.000135	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—FGF2—malignant glioma	8.82e-05	0.000135	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—ERBB2—malignant glioma	8.81e-05	0.000135	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—KRAS—malignant glioma	8.8e-05	0.000135	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TP53—malignant glioma	8.79e-05	0.000135	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PIK3CA—malignant glioma	8.78e-05	0.000135	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PIK3CG—malignant glioma	8.77e-05	0.000135	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—STAT3—malignant glioma	8.73e-05	0.000134	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TERT—malignant glioma	8.71e-05	0.000134	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PIK3CB—malignant glioma	8.69e-05	0.000133	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FGF2—malignant glioma	8.6e-05	0.000132	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PDGFB—malignant glioma	8.5e-05	0.00013	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TP53—malignant glioma	8.49e-05	0.00013	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PPARG—malignant glioma	8.47e-05	0.00013	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FGFR1—malignant glioma	8.45e-05	0.00013	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—AKT1—malignant glioma	8.42e-05	0.000129	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HIF1A—malignant glioma	8.33e-05	0.000128	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MDM2—malignant glioma	8.25e-05	0.000127	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—RAF1—malignant glioma	8.22e-05	0.000126	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—ERBB2—malignant glioma	8.13e-05	0.000125	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MYC—malignant glioma	8.11e-05	0.000124	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—PIK3CA—malignant glioma	8.08e-05	0.000124	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CAV1—malignant glioma	8.05e-05	0.000124	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MDM2—malignant glioma	8.05e-05	0.000123	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PIK3CB—malignant glioma	8.03e-05	0.000123	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—RAF1—malignant glioma	8.02e-05	0.000123	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL1B—malignant glioma	8.01e-05	0.000123	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL2—malignant glioma	7.98e-05	0.000122	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KDR—malignant glioma	7.96e-05	0.000122	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PTGS2—malignant glioma	7.95e-05	0.000122	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ERBB2—malignant glioma	7.94e-05	0.000122	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—EGFR—malignant glioma	7.94e-05	0.000122	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PIK3CB—malignant glioma	7.83e-05	0.00012	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PIK3CD—malignant glioma	7.71e-05	0.000118	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—F2—malignant glioma	7.67e-05	0.000118	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FN1—malignant glioma	7.67e-05	0.000118	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—BAD—malignant glioma	7.57e-05	0.000116	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CXCL8—malignant glioma	7.53e-05	0.000115	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PTEN—malignant glioma	7.51e-05	0.000115	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NOTCH1—malignant glioma	7.5e-05	0.000115	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—KRAS—malignant glioma	7.5e-05	0.000115	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—AKT1—malignant glioma	7.43e-05	0.000114	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—AKT1—malignant glioma	7.42e-05	0.000114	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CD80—malignant glioma	7.35e-05	0.000113	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—APC—malignant glioma	7.34e-05	0.000113	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PIK3CG—malignant glioma	7.34e-05	0.000113	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—AKT1—malignant glioma	7.27e-05	0.000111	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EGF—malignant glioma	7.25e-05	0.000111	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PTPN11—malignant glioma	7.21e-05	0.000111	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CASP3—malignant glioma	7.2e-05	0.00011	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL2—malignant glioma	7.19e-05	0.00011	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—AKT1—malignant glioma	7.17e-05	0.00011	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PTEN—malignant glioma	6.94e-05	0.000106	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—BRAF—malignant glioma	6.9e-05	0.000106	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PIK3CA—malignant glioma	6.89e-05	0.000106	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MMP9—malignant glioma	6.81e-05	0.000104	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PTEN—malignant glioma	6.77e-05	0.000104	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PIK3CB—malignant glioma	6.72e-05	0.000103	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—STAT3—malignant glioma	6.72e-05	0.000103	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AKT2—malignant glioma	6.71e-05	0.000103	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TP53—malignant glioma	6.66e-05	0.000102	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PTGS2—malignant glioma	6.66e-05	0.000102	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—AKT1—malignant glioma	6.6e-05	0.000101	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PIK3CD—malignant glioma	6.45e-05	9.89e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—STAT3—malignant glioma	6.2e-05	9.51e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FGF2—malignant glioma	6.17e-05	9.47e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—VEGFA—malignant glioma	6.11e-05	9.37e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—EGFR—malignant glioma	6.11e-05	9.36e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—STAT3—malignant glioma	6.05e-05	9.28e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PTEN—malignant glioma	5.81e-05	8.91e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MDM2—malignant glioma	5.78e-05	8.86e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—KRAS—malignant glioma	5.77e-05	8.85e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MYC—malignant glioma	5.76e-05	8.84e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—RAF1—malignant glioma	5.76e-05	8.83e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ERBB2—malignant glioma	5.7e-05	8.74e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—EGFR—malignant glioma	5.64e-05	8.65e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AKT1—malignant glioma	5.63e-05	8.63e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MYC—malignant glioma	5.62e-05	8.62e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PIK3CB—malignant glioma	5.62e-05	8.62e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EGFR—malignant glioma	5.5e-05	8.44e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCL8—malignant glioma	5.4e-05	8.28e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—KRAS—malignant glioma	5.33e-05	8.17e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PIK3CA—malignant glioma	5.3e-05	8.13e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KRAS—malignant glioma	5.2e-05	7.97e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CASP3—malignant glioma	5.17e-05	7.93e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL2—malignant glioma	5.16e-05	7.92e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PIK3CA—malignant glioma	4.89e-05	7.5e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MMP9—malignant glioma	4.89e-05	7.49e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PTEN—malignant glioma	4.86e-05	7.45e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PIK3CA—malignant glioma	4.77e-05	7.32e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TP53—malignant glioma	4.62e-05	7.08e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—VEGFA—malignant glioma	4.39e-05	6.73e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—STAT3—malignant glioma	4.34e-05	6.66e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—AKT1—malignant glioma	4.33e-05	6.64e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PIK3CA—malignant glioma	4.1e-05	6.28e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MYC—malignant glioma	4.04e-05	6.19e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—AKT1—malignant glioma	4e-05	6.13e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EGFR—malignant glioma	3.95e-05	6.05e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AKT1—malignant glioma	3.9e-05	5.98e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KRAS—malignant glioma	3.73e-05	5.72e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PIK3CA—malignant glioma	3.43e-05	5.26e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—AKT1—malignant glioma	3.35e-05	5.13e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TP53—malignant glioma	3.31e-05	5.08e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AKT1—malignant glioma	2.8e-05	4.29e-05	CbGpPWpGaD
